Advertisement
New Zealand markets open in 4 hours 34 minutes
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5946
    +0.0009 (+0.15%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • OIL

    82.59
    -0.22 (-0.27%)
     
  • GOLD

    2,341.70
    +3.30 (+0.14%)
     

How GlaxoSmithKline’s Vaccines Business Has Performed Recently

How GlaxoSmithKline’s Vaccines Business Has Performed Recently

GlaxoSmithKline’s (GSK) Vaccines segment includes influenza vaccines, meningitis vaccines, shingles vaccines, and established vaccines. The vaccines segment reported revenues of ~1.3 billion pounds during the second quarter of 2018, a 13% increase in YoY revenues. The growth includes a 16% increase in operating revenues offset by a 3% negative impact of foreign exchange during the quarter.